|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, March 03, 2017 ) Subtitle: The Cloudbased Drug Discovery Platform Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Cloudbased Drug Discovery Platform Market: Drivers and Challenges
the cloud-based drug discovery platform is enough flexible to deal with any types of research and development platform, through this customization users can create their own pipeline or protocol. Currently, cloud-based drug discovery platform is getting more developed by adding more features such as publishing and sharing services. Cloud-based drug discovery platform is accessible by computers, notebook and mobile as well. Cloud-based drug discovery platform is secure and can be maintained by a third party as well. For all these benefits, the cloud-based drug discovery platform market is anticipated to grow at a significant rate in terms of value.
ata management is a critical issue for the pharmaceutical industry. The pharmaceutical industry is rapidly restructuring its discovery business model to completely networked and integrated research and development in order to manage the huge data. This big data concept is main growth driver for the cloud-based drug discovery platform market. Graphical representation is a dynamic and quick form of getting a result which is easy for decision making in a management level, understanding the demand of consumers, companies are offering cloud-based drug discovery platform accordingly. Cloud-based drug discover platform runts at zero lag time, that’s saves time for the users. This is another reason why pharmaceutical companies adopt cloud-based drug discover platform.
Geographically, global cloud-based drug discovery market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. North America, Western Europe are the major shareholder of cloud-based drug discovery platform market. Asia pacific market for cloud-based drug discovery platform is expected to fuel the cloud-based drug discovery platform market in the near future.
However, many companies do not what to keep their confidential data in the cloud storage of the service provider which is a restraining factor for the cloud-based drug discover platform market. Moreover, due to high maintenance cost many small and medium scale pharmaceutical companies do not like to enter into Cloud-Based Drug Discovery Platform.
Cloudbased Drug Discovery Platform Market: Regional Overview
Since, huge number of drug discovery centre are located in North America, Japan and Western Europe regions, these are the potential market for cloud-based drug discovery platform market. Many companies from this region already adopted and using cloud-based drug discovery platform, however the regions is not penetrated and have significant opportunities for cloud-based drug discovery platform market.
Cloudbased Drug Discovery Platform Market: Key Players
Some of the key players operating in the cloud-based drug discovery platform market IBM Corp, Accenture PLC, BioXcel Corporation, Cloud Pharmaceuticals, Inc., WuXi AppTec (Shanghai) Co., Ltd., dassault systèmes biovia ltd.
Persistence Market Research
Rahul Singh
+1-646-568-7751
rahul@persistencemarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
